Achieve Life Sciences, Inc.

Finanzen von Achieve Life Sciences, Inc. (QUIT)

$6.060

-0.249 (-4.11%)Zum Schluss

Profitabilität und Margen von QUIT

Evaluating the bottom line, Achieve Life Sciences, Inc. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -104.23%, provide a clear picture of how effectively QUIT converts its operational activities into shareholder value.

QUIT im Vergleich zur Peergroup

In the context of the broader market, QUIT competes directly with industry leaders such as IMMX and OLMA. With a market capitalization of $666.78M, it holds a leading position in the sector. When comparing efficiency, QUIT's gross margin of N/A stands against IMMX's N/A and OLMA's N/A. Such benchmarking helps identify whether Achieve Life Sciences, Inc. is trading at a premium or discount relative to its financial performance.

Finanzielle Entwicklung von Achieve Life Sciences, Inc.

BDJ has demonstrated robust financial performance with a 1-year change of +8.67% and a year-to-date change of +2.77%, reflecting positive momentum in its price.

Financials

FY2026Q3
0.00
Total Revenue
FY2026Q3
YoY:
+39.77%
-20.54M
Operating Profit
FY2026Q3
YoY:
-16.14%
-12.11M
Net Income after Tax
FY2026Q3
YoY:
-25.96%
-8.39M
Free Cash Flow

Ähnliche Artikel

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln